Business
ProFrac is a U.S. well stimulation services provider with pressure pumping, proppant production, chemicals, and manufacturing assets across major unconventional basins.
ProFrac cut capex and debt, but revenue fell, losses widened, and free cash flow dropped sharply.
The read at a glance✓ Audited against SEC data
- Business mix — U.S. well stimulation and frac sand providerNote
- Revenue — Revenue -11.4% to $1.94BWatch
- Profitability — Net loss widened to $369MWatch
- Cash quality — Free cash flow -82.5% to $19.6MWatch
- Balance sheet — Debt lower, equity -28.7%Watch
- Insiders — 3 buys / 0 sells; $20.1M totalOK
- Accounting — Altman-Z distress; EQ safeWatch
Where the revenue comes from
Fiscal 2025, as ProFrac Holding Corp. reports it. History and quarterly detail are in the app.
- Stimulation Services$1.7B
- Proppant Production$336.0M
- Flotek$243.6M
- Manufacturing$212.3M
- All Other Segments$17.3M
Leadership changes
From ProFrac Holding Corp.'s own filings, the day they're filed.
- Matthew Rinaldi · Directors · appointmenteff. 2025-12-17
- Michael Henry · principal accounting officer · appointmenteff. 2024-09-25
- Austin Harbour · Chief Financial Officer · appointmenteff. 2024-06-17
Latest filings
- 8-K · Company announcement2026-08-06
- 10-Q · Quarterly report2026-08-06
- 8-K · Company announcement2026-07-06
- 8-K · Company announcement2026-06-01
- 10-Q · Quarterly report2026-05-08
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- Main tension🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about ProFrac Holding Corp., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.